Evidence map›Paper›PMID 34766475›Full record

SynthesisCancer reports (Hoboken, N.J.)2022

Urinary estrogen metabolites and gastric cancer risk among postmenopausal women.

M Constanza Camargo, Minkyo Song, Xia Xu, Isaac Zhao, Joshua N Sampson, Arash Etemadi, Hermann Brenner, Hwi-Won Lee, Britton Trabert, Bernd Holleczek and 9 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Cancer reports (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 5 countries.

M Constanza CamargoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.ORCID 0000-0002-1065-2198
Minkyo SongDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.ORCID 0000-0002-9412-2871
Xia XuCancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Isaac ZhaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Joshua N SampsonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Arash EtemadiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Hermann BrennerDivision of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany.
Hwi-Won LeeDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Britton TrabertDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Bernd HolleczekDivision of Clinical Epidemiology and Ageing Research, German Cancer Research Center, Heidelberg, Germany.
Ben SchöttkerDivision of Clinical Epidemiology and Ageing Research, German Cancer Research Center, Heidelberg, Germany.
Kathleen SpaidDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Sanford M DawseyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Sangjun LeeDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.ORCID 0000-0003-4080-0494
Takaya ShimuraDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Sue K ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Reza MalekzadehDigestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Daehee KangDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Charles S RabkinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
National Cancer Institute · USSeoul National University · KRGerman Cancer Research Center · DELeidos (United States) · USNagoya City University · JPNational Institutes of Health Clinical Center · USTehran University of Medical Sciences · IR

Funding

Upper Gastrointestinal Cancer StudiesZIACP000185 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$25.6M
6 · The paper itself

Abstract

backgroundThe overall incidence of gastric cancer in women is half that in men for most global populations. Sex hormone pathways may be involved in carcinogenesis and estrogens have been postulated to protect women against gastric cancer.

aimTo evaluate associations of gastric cancer with estrogen metabolites in postmenopausal women. METHODS AND

resultsWe performed an analysis of 233 gastric cancer cases and 281 age-matched controls from three prospective cohorts and two case-control studies of early-stage gastric cancer, mainly conducted in high-risk Asian populations. Fifteen estrogen-parent (estrone and estradiol) and -metabolite analytes (2-hydroxyestrone, 2-hydroxyestradiol, 2-hydroxyestrone-3-methyl ether, 4-hydroxyestrone; 4-methoxyestrone, 4-methoxyestradiol, 2-methoxyestrone, 2-methoxyestradiol, estriol, 16α-hydroxyestrone, 16-ketoestradiol, 16-epiestriol, and 17-epiestriol) were measured in spot urines using liquid chromatography-tandem mass spectrometry. Odds ratios for association with each marker were estimated by logistic regression. Heterogeneity was assessed by Cochran's Q test. Study-specific odds ratios were pooled by fixed-effects meta-analysis. Urinary levels of estrogen-related molecules were not associated with gastric cancer (adjusted odds ratios ranged from 0.87 to 1.27; p-values >.05), with low between-study heterogeneity (p-values >.1) for all but two metabolites (2-hydroxyestrone-3-methyl ether and 2-methoxyestradiol).

conclusionTo date, this is the first comprehensive assessment of endogenous estrogens with gastric cancer risk in women. Estrogens do not appear to have an etiologic role in gastric cancer risk among postmenopausal women. Given the complex network of sex steroid hormones and their extreme variation over the lifespan, further evaluation of this hypothesis is warranted.

Indexed as

Methyl EthersStomach Neoplasms2-MethoxyestradiolEstriolEstrogensFemaleHumansMalePostmenopauseProspective Studies2-MethoxyestradiolEstriolEstrogensMethyl Ethersestradiolestrogensestronegastric cancersex hormones

Identifiers

PMID34766475
PMCPMC9327671
OpenAlexW3213063946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.